
Can this under-the-radar company cash in on the $150 bn weight-loss drug boom?
Onesource Specialty Pharma Ltd, which demerged from Strides Pharma Science Ltd and listed on 24 January 2025, wants it, too. The company is building capacity, developing complex products, and onboarding global customers. Revenue from weight-loss drug …